Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
iDi icon

2.0.0 by Back2Medical


Jun 12, 2018

About iDi

Self-diagnosis, information and monitoring erectile dysfunction mobile app

First mobile app for patients about erectile dysfunction management.

Erectile disorders affect many men (40% over 45 years). It's a sensitive subject.

With iDi you can:

- Make a self- diagnosis of erectile dysfunction .

- Get clear and practical information on the different treatments of erectile dysfunction (pills, local treatments , intra- cavernous injections , vacuum erection device , penile implant)

- Get personal advice to support the most of your erectile dysfunction .

- Invite you to complete a questionnaire in order to better understand your troubles .

IDI's objective is to improve patient management suffering from ED.

The authors of the application are independent of the pharmaceutical industry.

iDi is the winner of the grand prix du jury Doc e'AWARD 2017.

What's New in the Latest Version 2.0.0

Last updated on Jun 12, 2018

Advanced flat design experience
Tutorial: know how to use iDi app with good tips!
Advice Wizard: get everyday new advices
Push Notifications: stay informed, iDi keeps in touch with you
Improved stability, this new app is faster and more stable!
Fix some bugs with AppRate

Translation Loading...

Additional APP Information

Latest Version

Request iDi Update 2.0.0

Uploaded by

ادم العراقي ادم

Requires Android

Android 4.1+

Show More

iDi Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.